Loading…
Loading…
NGC (Northern Genesis Acquisition Corp. III) is no longer actively trading.
This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.
NGC does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for NGC and 80,000+ other tickers.
See exactly how NGC's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for NGC and 80,000+ other tickers.
Northern Genesis Acquisition Corp. III currently lacks substantial operational activities. Its core mission is to execute a strategic business combination, which may encompass a merger, an exchange of capital stock, an acquisition of assets, a stock purchase, a corporate reorganization, or a comparable transaction, with one or more existing businesses or entities. The company was formed in 2021 and has its primary location in Kansas City, Missouri.
BP has agreed to sell a 20% stake in the Venezuelan portion of the cross-border Cocuina-Manakin natural gas field to Trinidad and Tobago's state-owned National Gas Company (NGC), two sources with knowledge of the matter said on Monday.
ROCHESTER, N.Y.--(BUSINESS WIRE)--L3Harris Technologies (NYSE: LHX) has received orders totaling $84 million in support of the U.S. Army for Next Generation Command and Control (NGC2) manpack Falcon® systems. The AN/PRC-158C systems include high-throughput Mobile Ad hoc NETworks (MANET) and highly resilient waveforms for assured communications in all conditions. This is L3Harris' second award in support of NGC2, following an initial $24 million order in October. The manpack systems will serve a.
Interim safety and efficacy data to be reported in Q1 VERO BEACH, Fla., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical-stage biopharmaceutical company developing Next Generation Cancer (NGC) therapies, today reported that it completed the enrollment and dosing of the 20 patients required for the planned formal interim analysis in its ongoing Phase 2 clinical study evaluating NGC-Cap, Processa's proprietary combination treatment of PCS6422 and capecitabine, in patients with advanced or metastatic breast cancer.
Northern Graphite Co. (CVE: NGC - Get Free Report) shot up 25.7% during mid-day trading on Saturday. The stock traded as high as C$0.23 and last traded at C$0.22. 511,438 shares traded hands during trading, an increase of 214% from the average session volume of 162,760 shares. The stock had previously closed at C$0.18. Northern
Northern Graphite Co. (CVE: NGC - Get Free Report)'s stock price traded up 25.7% during trading on Saturday. The company traded as high as C$0.23 and last traded at C$0.22. 511,438 shares were traded during trading, an increase of 214% from the average session volume of 162,760 shares. The stock had previously closed at C$0.18.